Retraction
LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway
Paper Information
Record ID:
21885
Journal:
Publication Date:
March 18, 2019
Retraction Date:
December 30, 2019
(5.9 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Medicine - Gastroenterology Medicine - Oncology
Biology - Cancer Biology - Cellular Medicine - Gastroenterology Medicine - Oncology
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (15)
15
Total Citations13
Post-Retraction(86.7%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
5
Within 1 year
6
After 2+ years
1587
Days since retraction (latest)
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: May 2024
1587 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Jul 2023
1292 days after retraction
Retraction Note: Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
Weilong Yao, Shengtao Zhu, Peng Li et al. (4 authors)
Cancer Cell International
Open Access
Published: Apr 2023
1204 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Apr 2023
1190 days after retraction
LncRNA AC026401.3 interacts with OCT1 to intensify sorafenib and lenvatinib resistance by activating E2F2 signaling in hepatocellular carcinoma
Yun Wang, Kai Tan, Wen Hu et al. (5 authors)
Experimental Cell Research
Published: Sep 2022
20 citations
20 citations
981 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Jul 2022
931 days after retraction
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
Jingyue Yao, Jubo Wang, Ye Xu et al. (9 authors)
Autophagy
Open Access
Published: Dec 2021
148 citations
148 citations
711 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Aug 2021
604 days after retraction
Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy
Yixiong Wang, Baozhu Xu, Jianying Zhou et al. (4 authors)
Journal of Gastrointestinal Oncology
Open Access
Published: Dec 2020
10 citations
10 citations
337 days after retraction
LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1
Yongping Zhou, Huang Yonggang, Tu Dai et al. (11 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2020
28 citations
28 citations
334 days after retraction
New insights on sorafenib resistance in liver cancer with correlation of individualized therapy
Cheng Zhang, Weiqi Jiang, Jin Ding
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Jun 2020
98 citations
98 citations
159 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Jan 2020
2 days after retraction
Paper citing LATS2 overexpression attenuates the therapeutic re...
Unknown Authors
Unknown Journal
Published: Jan 2020
2 days after retraction
Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway
Jie Song, Wei Zhao, Chang Lu et al. (4 authors)
Cancer Cell International
Open Access
Published: Dec 2019
2 citations
2 citations
29 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
5.9 years
Open Access:
Yes
Last Checked:
Never